[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$bmys Graphic](https://lunarcrush.com/gi/w:26/t:$bmys.png) $bmys

$BMYs faces a setback as the FDA rejects a key application, leading to downgrades. However, positive analysis suggests potential for future growth and market expansion.

### About $bmys
A pharmaceutical company.  

### Insights [#](/topic/$bmys/insights)
- $bmys creators is up XX% from the previous week.
- $bmys mentions is up XX% from the previous week.

### Engagements: XXX [#](/topic/$bmys/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$bmys/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/$bmys/time-series/interactions.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Month**: XXXXX +314%  
**1-Year High**: XXX on 2025-05-15  
**1-Year Low**: X on 2025-06-22  

| Social Network | X   |
| -------------- | -   |
| Engagements    | XXX |
  

  
  
### Mentions: X [#](/topic/$bmys/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$bmys/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/$bmys/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1 Week**: X +50%  
**1 Month**: X +50%  
**1-Year High**: X on 2025-04-27  
**1-Year Low**: X on 2025-04-29  

| Social Network | X |
| -------------- | - |
| Mentions       | X |
  

  
  
### Creators: X [#](/topic/$bmys/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$bmys/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/$bmys/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $bmys in the last XX hours which is no change from in the previous XX hours
**Daily Average**: X  
**1 Week**: X +50%  
**1 Month**: X +50%  
**1-Year High**: X on 2025-04-27  
**1-Year Low**: X on 2025-04-29  
  
  
### Sentiment: undefined% [#](/topic/$bmys/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$bmys/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$bmys/time-series/sentiment.tsv)  

**Top topics mentioned**
In the posts about $bmys in the last XX hours

[hc](/topic/hc), [$barcl](/topic/$barcl), [rating agency](/topic/rating-agency), [combo](/topic/combo), [investment](/topic/investment), [$2b](/topic/$2b), [superior](/topic/superior), [dec](/topic/dec)

### Top Social Posts [#](/topic/$bmys/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$REPL Replimune rebounds despite FDA rejection and multiple downgrades via Shares plummeted -XX% on Tuesday after FDA rejected RP1 application for advanced melanoma (combo with $BMYs Opdivo) Wednesday rebound: +24.24% despite analyst downgrades BMO: Downgrade to Underperform PT cut to $X Barclays: Downgrade to Equal Weight PT slashed to $X (from $17) H.C. Wainwright: Downgrade to Neutral from Buy Concerns over funding and need to rerun clinical trials per FDA feedback"  
[@overnight_stock](/creator/x/overnight_stock) on [X](/post/tweet/1948044796523585938) 2025-07-23 15:37:27 UTC XXX followers, XXX engagements


"Long Cytokinetics $CYTK. My analysis points to a $XX PT (+36% upside)-1 year timeframe. Thesis: Aficamten PDUFA: Dec XX 2025. High probability of approval for oHCM. Superior Profile: Better efficacy & safety vs. $BMY's Camzyos. TAM Expansion: ACACIA trial in nHCM could unlock a $2B+ market. Funded: Cash runway through commercialization. #Biotech #Investing #Cardiology #PDUFA"  
[@bs2537](/creator/x/bs2537) on [X](/post/tweet/1947363591167893642) 2025-07-21 18:30:35 UTC 7866 followers, 1280 engagements